Quantitative determination of efavirenz (DMP 266), a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection-Reference-Cited by-同舟云学术

Quantitative determination of efavirenz (DMP 266), a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection

Published:1999-10 Issue:1 Volume:734 Page:55-61
ISSN:0378-4347
Container-title:Journal of Chromatography B: Biomedical Sciences and Applications
language:en
Short-container-title:Journal of Chromatography B: Biomedical Sciences and Applications

Author:

Veldkamp Agnes I,van Heeswijk Rolf P.G,Meenhorst Pieter L,Mulder Jan W,Lange Joep M.A,Beijnen Jos H,Hoetelmans Richard M.W

Publisher

Elsevier BV

Subject

General Chemistry

Reference10 articles.

1. Efavirenz

2. Du Pont Pharmaceuticals Company, Sustiva (efavirenz capsules), prescribing information, 17 Sept. 1998; http://www.sustiva.com

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. QbD based RP-HPLC method for simultaneous determination of a emtricitabine, tenofovir diproxil fumarate and efavirenz in tablet dosage form-an application to stability indicating assay;Analytical Chemistry Letters;2023-05-04

2. A Concise Analytical Profile of Efavirenz: Analytical Methodologies;Critical Reviews in Analytical Chemistry;2021-03-15

3. DEVELOPMENT AND VALIDATION OF NOVEL ANALYTICAL METHODS FOR ASSAY OF EFAVIRENZ IN PHARMACEUTICAL FORMULATIONS;INDO AM J PHARM SCI;2019

4. Bio-analytical Assay Methods used in Therapeutic Drug Monitoring of Antiretroviral Drugs-A Review;Current Drug Therapy;2019-03-06

5. The use of experimental design for the development and validation of an HPLC-ECD method for the quantitation of efavirenz;PHARMAZIE;2018